Cullinan Oncology Inc.
(CGEM)
undefined
undefined%
At close: undefined
11.75
-0.17%
After-hours Dec 13, 2024, 04:15 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | - | - | 18.94M | - | - | - |
Cost of Revenue | 310.00K | 93.00K | 53.00K | 62.00K | 70.00K | 43.00K |
Gross Profit | -310.00K | -93.00K | 18.89M | -62.00K | -70.00K | -43.00K |
Operating Income | -191.09M | 144.65M | -67.95M | -60.34M | -22.27M | -14.59M |
Interest Income | 21.63M | 6.61M | 477.00K | 888.00K | 620.00K | 397.00K |
Pretax Income | -169.22M | 151.32M | -67.48M | -59.46M | -21.65M | -14.19M |
Net Income | -153.16M | 111.21M | -65.04M | -50.85M | -20.04M | -14.19M |
Selling & General & Admin | 42.49M | 40.19M | 29.15M | 17.12M | 5.48M | 5.00M |
Research & Development | 148.16M | 91.95M | 57.75M | 43.21M | 16.79M | 9.58M |
Other Expenses | 440.00K | 57.00K | -8.00K | -11.00K | -4.00K | - |
Operating Expenses | 191.09M | 132.14M | 86.90M | 60.34M | 22.27M | 14.59M |
Interest Expense | - | - | - | - | - | - |
Selling & Marketing Expenses | - | - | - | - | - | - |
Cost & Expenses | 191.09M | 132.14M | 86.90M | 60.34M | 22.27M | 14.59M |
Income Tax | -14.12M | 42.12M | -2.44M | -8.61M | -1.62M | 397.00K |
Shares Outstanding (Basic) | 41.51M | 45.16M | 44.29M | 43.52M | 43.52M | 11.45M |
Shares Outstanding (Diluted) | 41.55M | 46.64M | 44.29M | 43.52M | 43.52M | 11.45M |
EPS (Basic) | -3.69 | 2.46 | -1.47 | -1.17 | -0.46 | -1.24 |
EPS (Diluted) | -3.69 | 2.38 | -1.47 | -1.17 | -0.46 | -1.24 |
EBITDA | -190.34M | 151.41M | -67.90M | -60.27M | -22.20M | -14.54M |
Depreciation & Amortization | 310.00K | 93.00K | 53.00K | 62.00K | 70.00K | 43.00K |